Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium/calmodulin-dependent protein kinase type IV (CAMK4) is a multifunctional serine/threonine kinase that operates as a key effector in calcium-triggered signaling cascades. Upon activation by calcium/calmodulin binding and phosphorylation by upstream CaMKKs, CAMK4 translocates to the nucleus where it phosphorylates transcription factors such as CREB and CREM, thereby regulating gene expression crucial for immune response, synaptic plasticity, and cell survival. In the immune system, CAMK4 is a critical driver of T-cell activation, Th17 cell differentiation, and osteoclastogenesis. Consequently, its overactivation is strongly implicated in the pathogenesis of autoimmune and inflammatory disorders, including systemic lupus erythematosus (SLE), lupus nephritis, and rheumatoid arthritis (RA). Additionally, CAMK4 dysregulation in the central nervous system is linked to neurological conditions such as depression and autism spectrum disorder. Although there are currently no selective CAMK4 inhibitors approved for clinical use, preclinical studies using tool compounds like KN-93 and cell-targeted nanoparticle delivery systems have shown great promise in mitigating autoimmune pathology and kidney damage, highlighting CAMK4 as a highly attractive therapeutic target.
Inhibition of kinase activity, typically through ATP-competitive or allosteric mechanisms, which blocks downstream phosphorylation of transcription factors like CREB and CREM.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium/calmodulin-dependent protein kinase type IV (CAMK4).